Russ H. Read
Russ H. Read has worked in the bioscience industry for over thirty five years. Formerly he was an executive with the Burroughs Wellcome and Glaxo Wellcome companies. He was heavily involved with the commercial development of antivirals like AZT and 3TC which are mainstay treatments for HIV illness. Russ has a special interest in the bioscience workforce. He was CEO of the Kucera Pharmaceutical Company- a start- up biopharmaceutical company based in Winston-Salem. He has recently led a national biotechnology workforce effort for nine years called the National Center for the Biotechnology Workforce (NCBW). The NCBW is based in Winston-Salem and was originally a large US DOL grant but is now a part of North Carolina’s BioNetwork. The NCBW focuses on achieving best practices for bioscience workforce training with its national partners, such as the US DOL and the NSF. A recent partner is The Manufacturing Institute based in Washington, D.C. In October 2012, a twelve member national consortium of community colleges, led by Forsyth Tech, won a $15 million US DOL Trade Adjustment Assistance grant looking at building biosciences workforce skill standards and credentials. Russ is the consortium’s Project Director. Russ is also the Principal Investigator for the NSF ATE Project grant named the Biosciences Industrial Fellowship Program. He currently serves as Past-Chair of the Advisory Committee for the NC Biotech Center’s Piedmont Triad regional office and is a Director of NC BIO. He also serves on the National Visitor’s Committee of the NSF ATE national program called Bio-Link and is an advisor to the NSF ATE NBC2 program.